- Home
- GURE vs GTBP Comparison
GURE vs GTBP Comparison
Compare GURE & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GURE
- GTBP
- Stock Information
- Founded
- GURE 2006
- GTBP 1965
- Country
- GURE China
- GTBP United States
- Employees
- GURE N/A
- GTBP N/A
- Industry
- GURE Major Chemicals
- GTBP Biotechnology: Pharmaceutical Preparations
- Sector
- GURE Industrials
- GTBP Health Care
- Exchange
- GURE Nasdaq
- GTBP Nasdaq
- Market Cap
- GURE 6.5M
- GTBP 6.6M
- IPO Year
- GURE 1992
- GTBP N/A
- Fundamental
- Price
- GURE $0.57
- GTBP $3.09
- Analyst Decision
- GURE
- GTBP Strong Buy
- Analyst Count
- GURE 0
- GTBP 1
- Target Price
- GURE N/A
- GTBP $11.00
- AVG Volume (30 Days)
- GURE 27.7K
- GTBP 1.1M
- Earning Date
- GURE 01-07-2025
- GTBP 11-14-2024
- Dividend Yield
- GURE N/A
- GTBP N/A
- EPS Growth
- GURE N/A
- GTBP N/A
- EPS
- GURE N/A
- GTBP N/A
- Revenue
- GURE $12,802,982.00
- GTBP N/A
- Revenue This Year
- GURE N/A
- GTBP N/A
- Revenue Next Year
- GURE N/A
- GTBP N/A
- P/E Ratio
- GURE N/A
- GTBP N/A
- Revenue Growth
- GURE N/A
- GTBP N/A
- 52 Week Low
- GURE $0.51
- GTBP $1.72
- 52 Week High
- GURE $1.79
- GTBP $10.66
- Technical
- Relative Strength Index (RSI)
- GURE 42.84
- GTBP 57.11
- Support Level
- GURE $0.59
- GTBP $1.72
- Resistance Level
- GURE $0.64
- GTBP $4.10
- Average True Range (ATR)
- GURE 0.06
- GTBP 0.49
- MACD
- GURE 0.00
- GTBP 0.05
- Stochastic Oscillator
- GURE 37.58
- GTBP 57.56
About GURE Gulf Resources Inc. (NV)
Gulf Resources Inc is a holding company engaged in the manufacture and trade of bromine and crude salt, and natural gas; manufactures and sells chemical products used in oil and gas field exploration, oil and gas distribution, oil field drilling, wastewater processing, papermaking chemical agents and inorganic chemicals, and manufactures and sells materials for human and animal antibiotics. It operates in four segments: Bromine, Crude Salt, Chemical Products and Natural Gas. It derives maximum revenue from the Bromine segment which is commonly used in brominated flame retardants, fumigants, water purification compounds, dyes, medicines and disinfectants.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.